ReP USP - Resultado da busca

Artigo de periodico
Global variation in lipoprotein(a) levels among patients with coronary heart disease insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies (2025)
Barkas, Fotios; Brandts, Julia; Bacquer, Dirk De; Jennings, Catriona; Backer, Guy G. De; Kotseva, Kornelia; Ryden, Lars; Lip, Gregory Y. H.; Santos Filho, Raul Dias dos ; Libby, Peter
Source: Journal of the American College of Cardiology. Unidade: FM
Subjects: LIPOPROTEÍNAS, DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARKAS, Fotios et al. Global variation in lipoprotein(a) levels among patients with coronary heart disease insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies. Journal of the American College of Cardiology, v. 85, n. 21, p. 2028-2042, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/88283. Acesso em: 24 abr. 2026.
APA
Barkas, F., Brandts, J., Bacquer, D. D., Jennings, C., Backer, G. G. D., Kotseva, K., et al. (2025). Global variation in lipoprotein(a) levels among patients with coronary heart disease insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies. Journal of the American College of Cardiology, 85( 21), 2028-2042. doi:10.1016/j.jacc.2025.04.010
NLM
Barkas F, Brandts J, Bacquer DD, Jennings C, Backer GGD, Kotseva K, Ryden L, Lip GYH, Santos Filho RD dos, Libby P. Global variation in lipoprotein(a) levels among patients with coronary heart disease insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies [Internet]. Journal of the American College of Cardiology. 2025 ; 85( 21): 2028-2042.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88283
Vancouver
Barkas F, Brandts J, Bacquer DD, Jennings C, Backer GGD, Kotseva K, Ryden L, Lip GYH, Santos Filho RD dos, Libby P. Global variation in lipoprotein(a) levels among patients with coronary heart disease insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies [Internet]. Journal of the American College of Cardiology. 2025 ; 85( 21): 2028-2042.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88283
Artigo de periodico-carta/editorial
Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients (2024)
Coelho, Otavio R; Santos Filho, Raul Dias dos
Source: European journal of preventive cardiology. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, ESCOLARIZAÇÃO, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Otavio R e SANTOS FILHO, Raul Dias dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients. European journal of preventive cardiology. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/76877. Acesso em: 24 abr. 2026. , 2024
APA
Coelho, O. R., & Santos Filho, R. D. dos. (2024). Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients. European journal of preventive cardiology. Oxford: Faculdade de Medicina, Universidade de São Paulo. doi:10.1093/eurjpc/zwad346
NLM
Coelho OR, Santos Filho RD dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients [Internet]. European journal of preventive cardiology. 2024 ; 31( 5): 519-520.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76877
Vancouver
Coelho OR, Santos Filho RD dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients [Internet]. European journal of preventive cardiology. 2024 ; 31( 5): 519-520.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76877
Artigo de periodico
Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations (2024)
Ponnaiah, Maharajah; Zakiev, Emile; Lhomme, Marie; Rached, Fabiana; Camont, Laurent; Serrano Junior, Carlos Vicente ; Santos Filho, Raul Dias dos ; Chapman, M. John; Orekhov, Alexander; Kontush, Anatol
Source: ATHEROSCLEROSIS PLUS. Unidade: FM
Subjects: LIPOPROTEÍNAS LDL, INFARTO DO MIOCÁRDIO, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONNAIAH, Maharajah et al. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. ATHEROSCLEROSIS PLUS, v. 55, p. 21-30, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58815. Acesso em: 24 abr. 2026.
APA
Ponnaiah, M., Zakiev, E., Lhomme, M., Rached, F., Camont, L., Serrano Junior, C. V., et al. (2024). Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. ATHEROSCLEROSIS PLUS, 55, 21-30. doi:10.1016/j.athplu.2023.12.001
NLM
Ponnaiah M, Zakiev E, Lhomme M, Rached F, Camont L, Serrano Junior CV, Santos Filho RD dos, Chapman MJ, Orekhov A, Kontush A. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations [Internet]. ATHEROSCLEROSIS PLUS. 2024 ; 55 21-30.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58815
Vancouver
Ponnaiah M, Zakiev E, Lhomme M, Rached F, Camont L, Serrano Junior CV, Santos Filho RD dos, Chapman MJ, Orekhov A, Kontush A. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations [Internet]. ATHEROSCLEROSIS PLUS. 2024 ; 55 21-30.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58815
Artigo de periodico
Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network (2024)
Espinosa-ortega, Fabricio; Lodin, Karin; Dastmalchi, Maryam; Vencovsky, Jiri; Diederichsen, Louise P.; Shinjo, Samuel Katsuyuki ; Danieli, Maria Giovanna; Selva-o'Callaghan, Albert; Visser, Marianne de; Griger, Zoltan
Source: Seminars in Arthritis and Rheumatism. Unidade: FM
Subjects: AUTOANTICORPOS, ESTUDOS LONGITUDINAIS, MIOPATIAS CONGÊNITAS ESTRUTURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESPINOSA-ORTEGA, Fabricio et al. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network. Seminars in Arthritis and Rheumatism, v. 68, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/79475. Acesso em: 24 abr. 2026.
APA
Espinosa-ortega, F., Lodin, K., Dastmalchi, M., Vencovsky, J., Diederichsen, L. P., Shinjo, S. K., et al. (2024). Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network. Seminars in Arthritis and Rheumatism, 68. doi:10.1016/j.semarthrit.2024.152529
NLM
Espinosa-ortega F, Lodin K, Dastmalchi M, Vencovsky J, Diederichsen LP, Shinjo SK, Danieli MG, Selva-o'Callaghan A, Visser M de, Griger Z. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network [Internet]. Seminars in Arthritis and Rheumatism. 2024 ; 68[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79475
Vancouver
Espinosa-ortega F, Lodin K, Dastmalchi M, Vencovsky J, Diederichsen LP, Shinjo SK, Danieli MG, Selva-o'Callaghan A, Visser M de, Griger Z. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: alongitudinal multicenter study from the MYONET international network [Internet]. Seminars in Arthritis and Rheumatism. 2024 ; 68[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79475
Artigo de periodico-carta/editorial
Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study (2022)
Sen, Parikshit; Lilleker, James B; Agarwal, Vishwesh; Kardes, Sinan; Milchert, Marcin; Gheita, Tamer; Salim, Babur; Velikova, Tsvetelina; Gracia-Ramos, Abraham Edgar; Shinjo, Samuel Katsuyuki
Source: Indian journal of rheumatology. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEN, Parikshit et al. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study. Indian journal of rheumatology. Mumbai: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.4103/injr.injr_221_21. Acesso em: 24 abr. 2026. , 2022
APA
Sen, P., Lilleker, J. B., Agarwal, V., Kardes, S., Milchert, M., Gheita, T., et al. (2022). Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study. Indian journal of rheumatology. Mumbai: Faculdade de Medicina, Universidade de São Paulo. doi:10.4103/injr.injr_221_21
NLM
Sen P, Lilleker JB, Agarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Shinjo SK. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study [Internet]. Indian journal of rheumatology. 2022 ; 17( 2): 188-191.[citado 2026 abr. 24 ] Available from: https://doi.org/10.4103/injr.injr_221_21
Vancouver
Sen P, Lilleker JB, Agarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Shinjo SK. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study [Internet]. Indian journal of rheumatology. 2022 ; 17( 2): 188-191.[citado 2026 abr. 24 ] Available from: https://doi.org/10.4103/injr.injr_221_21
Artigo de periodico
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction (2022)
Butler, Javed ; Filippatos, Gerasimos ; Siddiqi, Tariq Jamal; Ferreira, Joao Pedro ; Brueckmann, Martina ; Bocchi, Edimar Alcides ; Bohm, Michael ; Chopra, Vijay K. ; Giannetti, Nadia ; Iwata, Tomoko
Source: Circulation. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, HOMENS, MULHERES, PACIENTES INTERNADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUTLER, Javed et al. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation, v. 146, n. 14, p. 1046-1055, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50467. Acesso em: 24 abr. 2026.
APA
Butler, J., Filippatos, G., Siddiqi, T. J., Ferreira, J. P., Brueckmann, M., Bocchi, E. A., et al. (2022). Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation, 146( 14), 1046-1055. doi:10.1161/CIRCULATIONAHA.122.059755
NLM
Butler J, Filippatos G, Siddiqi TJ, Ferreira JP, Brueckmann M, Bocchi EA, Bohm M, Chopra VK, Giannetti N, Iwata T. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction [Internet]. Circulation. 2022 ; 146( 14): 1046-1055.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50467
Vancouver
Butler J, Filippatos G, Siddiqi TJ, Ferreira JP, Brueckmann M, Bocchi EA, Bohm M, Chopra VK, Giannetti N, Iwata T. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction [Internet]. Circulation. 2022 ; 146( 14): 1046-1055.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50467
Artigo de periodico-carta/editorial
Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment?. [Editorial] (2022)
Bocchi, Edimar Alcides ; Ventura, Hector O
Source: Jacc-heart failure. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, SOBREVIDA, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCHI, Edimar Alcides e VENTURA, Hector O. Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment? [Editorial]. Jacc-heart failure. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jchf.2022.02.017. Acesso em: 24 abr. 2026. , 2022
APA
Bocchi, E. A., & Ventura, H. O. (2022). Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment? [Editorial]. Jacc-heart failure. Oxford: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.jchf.2022.02.017
NLM
Bocchi EA, Ventura HO. Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment? [Editorial] [Internet]. Jacc-heart failure. 2022 ; 10( 6): 393-396.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1016/j.jchf.2022.02.017
Vancouver
Bocchi EA, Ventura HO. Systemic blood pressure in heart failure the next frontier in prognosis and chronic HF treatment? [Editorial] [Internet]. Jacc-heart failure. 2022 ; 10( 6): 393-396.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1016/j.jchf.2022.02.017
Artigo de periodico
The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis? (2022)
Bocchi, Edimar Alcides ; Lima, Ivna Girard Cunha Vieira
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: RESULTADO DE TRATAMENTO, INSUFICIÊNCIA CARDÍACA, FÁRMACOS SINTÉTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCHI, Edimar Alcides e LIMA, Ivna Girard Cunha Vieira. The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis?. Journal of the american college of cardiology, v. 80, n. 6, p. 595-597, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50443. Acesso em: 24 abr. 2026.
APA
Bocchi, E. A., & Lima, I. G. C. V. (2022). The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis? Journal of the american college of cardiology, 80( 6), 595-597. doi:10.1016/j.jacc.2022.05.028
NLM
Bocchi EA, Lima IGCV. The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis? [Internet]. Journal of the american college of cardiology. 2022 ; 80( 6): 595-597.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50443
Vancouver
Bocchi EA, Lima IGCV. The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy Quo Vadis? [Internet]. Journal of the american college of cardiology. 2022 ; 80( 6): 595-597.[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50443
Artigo de periodico
Clinical Genetic Testing for Familial Hypercholesterolemia (2018)
Sturm, Amy C.; Santos, Raul D.
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, COLESTEROL, CUSTOS DOS CUIDADOS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STURM, Amy C. e SANTOS, Raul D. Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, v. 72, n. 6, p. 662-680, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.05.044. Acesso em: 24 abr. 2026.
APA
Sturm, A. C., & Santos, R. D. (2018). Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, 72( 6), 662-680. doi:10.1016/j.jacc.2018.05.044
NLM
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044
Vancouver
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044
Artigo de periodico
Familial hypercholesterolaemia (2017)
Defesche, Joep C.; Gidding, Samuel S.; Harada-Shiba, Mariko; Santos Filho, Raul Dias dos; Wierzbicki, Anthony S.
Source: Nature reviews disease primers. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, COLESTEROL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEFESCHE, Joep C. et al. Familial hypercholesterolaemia. Nature reviews disease primers, v. 3, 2017Tradução . . Disponível em: https://doi.org/10.1038/nrdp.2017.93. Acesso em: 24 abr. 2026.
APA
Defesche, J. C., Gidding, S. S., Harada-Shiba, M., Santos Filho, R. D. dos, & Wierzbicki, A. S. (2017). Familial hypercholesterolaemia. Nature reviews disease primers, 3. doi:10.1038/nrdp.2017.93
NLM
Defesche JC, Gidding SS, Harada-Shiba M, Santos Filho RD dos, Wierzbicki AS. Familial hypercholesterolaemia [Internet]. Nature reviews disease primers. 2017 ; 3[citado 2026 abr. 24 ] Available from: https://doi.org/10.1038/nrdp.2017.93
Vancouver
Defesche JC, Gidding SS, Harada-Shiba M, Santos Filho RD dos, Wierzbicki AS. Familial hypercholesterolaemia [Internet]. Nature reviews disease primers. 2017 ; 3[citado 2026 abr. 24 ] Available from: https://doi.org/10.1038/nrdp.2017.93

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration